All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Two months on testosterone: what the science says about early TRT results

Grayson Smith

TikTok creator

143.3K viewsWatch on TikTok→

Quick answer

The creator describes initiating testosterone replacement therapy after labs confirmed low levels, with symptoms including fatigue, brain fog, and general malaise, which are consistent with female hypogonadism. At two months, she reports symptomatic improvement and a fourfold increase in testosterone levels, though the absolute values and whether levels are now within physiologic range for women are not disclosed. Two months is insufficient to assess the full side effect profile or long-term efficacy of testosterone therapy in female patients.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @grayson.smith12 actually say?

Grayson described going to a hormone clinic, getting labs that showed "really, really, really low" testosterone, and starting testosterone replacement therapy on her nurse's recommendation. After two months, she says she no longer has the "mid-day crash" and feels better overall. She also reports zero side effects, and claims her levels "quadrupled" at her two-month checkup.

She's careful to hedge, saying "I'm not sure if it's a placebo thing or what." That's actually a more honest disclosure than most TRT content on TikTok. She stops short of telling viewers to go on testosterone, and instead suggests getting levels tested. Her recommendation is mostly reasonable, but there are some gaps in the clinical picture she's painting that are worth unpacking.

Does the science back this up?

Partly, yes. Female hypogonadism is real, underdiagnosed, and genuinely associated with fatigue, brain fog, and low energy. The symptom improvement she describes is consistent with what the literature shows for women with documented low testosterone.

A 2019 systematic review by Davis et al. in The Lancet Diabetes and Endocrinology found that testosterone therapy in women improved sexual function and some quality-of-life markers, but the evidence for fatigue and cognitive symptoms specifically is still limited and context-dependent. The placebo response in hormone studies is also well-documented and can account for significant symptom relief in the short term, which Grayson herself acknowledges. A 2014 trial by Rao et al. in JAMA found that placebo arms in testosterone studies sometimes show 30-40% symptom improvement. Two months is also not enough time to draw firm conclusions about long-term efficacy or safety in most endocrine protocols.

What did they get wrong (or right)?

She got the basic premise right: if your testosterone is genuinely low and symptomatic, replacement therapy can help. Credit where it's due.

What she got wrong, or at least incomplete, is the side effect picture. She says she "hasn't experienced any of the negative side effects," but two months is a very short window. Acne and hair growth can emerge later as levels stabilize or if dosing shifts. More importantly, she doesn't mention other potential effects that matter in female patients, including changes to menstrual cycles, clitoral sensitivity, voice changes, and lipid profile shifts. A 2021 review by Islam et al. in Clinical Endocrinology noted that androgenic side effects in women often appear after 3-6 months, not in the first eight weeks. Her clean bill of health at two months is not the full story.

The claim that her levels "quadrupled" also needs context. Quadrupling from severely deficient to normal is the goal. Quadrupling into supraphysiologic range would be a problem. She doesn't say where her levels landed, and that distinction matters clinically.

What should you actually know?

Low testosterone in women is a real and underrecognized condition, but diagnosis is genuinely complicated. Reference ranges for female testosterone vary significantly by lab and by age, and many standard lab panels don't capture free testosterone or SHBG, which affect how much testosterone is actually bioavailable. Getting a number without the full panel can be misleading.

If you're experiencing fatigue, brain fog, and low energy, testosterone is one possible explanation, but it is far from the only one. Thyroid dysfunction, iron deficiency, sleep apnea, and mood disorders can all produce identical symptoms and should be ruled out before starting hormone therapy. The Endocrine Society's 2014 clinical practice guidelines explicitly recommend against treating women with testosterone unless there is both a documented low level and clear symptoms that haven't responded to other interventions.

Grayson's advice to get your levels tested is reasonable. Her implicit suggestion that a hormone clinic is the right first stop is worth questioning. A primary care physician or endocrinologist with full labs is a better starting point for most people.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Two months on testosterone: what the science says about early TRT results, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Two months on testosterone: what the science says about early TRT results should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

The creator describes initiating testosterone replacement therapy after labs confirmed low levels, with symptoms including fatigue, brain fog, and general malaise, which are consistent with female hypogonadism.

FormBlends verdict

The creator describes initiating testosterone replacement therapy after labs confirmed low levels, with symptoms including fatigue, brain fog, and general malaise, which are consistent with female hypogonadism. At two months, she reports symptomatic improvement and a fourfold increase in testosterone levels, though the absolute values and whether levels are now within physiologic range for women are not disclosed. Two months is insufficient to assess the full side effect profile or long-term efficacy of testosterone therapy in female patients.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator describes initiating testosterone replacement therapy after labs confirmed low levels, with symptoms including fatigue, brain fog, and general malaise, which are consistent with female hypogonadism. At two months, she reports symptomatic improvement and a fourfold increase in testosterone levels, though the absolute values and whether levels are now within physiologic range for women are not disclosed. Two months is insufficient to assess the full side effect profile or long-term efficacy of testosterone therapy in female patients.
  • Female testosterone deficiency is real, but reference ranges vary by lab and age, and most standard panels miss free testosterone and SHBG, the values that reflect how much is actually bioavailable.
  • A 2019 systematic review (Davis et al., Lancet Diabetes and Endocrinology) found evidence for testosterone therapy in women is strongest for sexual function, and much weaker for fatigue and cognitive symptoms specifically.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Female testosterone deficiency is real, but reference ranges vary by lab and age, and most standard panels miss free testosterone and SHBG, the values that reflect how much is actually bioavailable.
  • A 2019 systematic review (Davis et al., Lancet Diabetes and Endocrinology) found evidence for testosterone therapy in women is strongest for sexual function, and much weaker for fatigue and cognitive symptoms specifically.
  • Two months is not enough to assess the full side effect profile. Islam et al. (2021, Clinical Endocrinology) found androgenic effects in women typically emerge at 3-6 months of therapy.
  • Placebo responses in testosterone trials can account for 30-40% symptom improvement (Rao et al., 2014, JAMA), which is why the creator's own uncertainty about placebo is actually the most scientifically honest part of her video.
  • Before attributing fatigue and brain fog to low testosterone, thyroid dysfunction, iron deficiency anemia, sleep apnea, and depression should all be ruled out, as these conditions produce identical symptoms.
  • The Endocrine Society's 2014 clinical practice guidelines recommend against treating women with testosterone unless both low levels are documented and symptoms have not responded to other interventions.
  • A fourfold increase in testosterone tells you very little without knowing the starting value and the landing value. Getting into normal physiologic range is the goal. Exceeding it is a clinical problem, not a success metric.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Grayson Smith · TikTok creator

143.3K views on this video

2 months on testosterone update #HormoneTherapy #Testosterone #FemaleTestosterone #TestosteroneReplacement #TestosteroneTherapy #Hormones.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Grayson Smith, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.